Example: Heart Attack

Clinical Trials Sponsored by Trillium Therapeutics Inc.

Total 4 results

NCT03530683

Recruiting

A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma

Conditions: Lymphoma; Myeloma
NCT02890368

Terminated

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Conditions: Solid Tumors; Mycosis Fungoides; Melanoma; Merkel-cell Carcinoma; Squamous Cell Carcinoma; Breast Carcinoma; Human Papillomavirus-Related Malignant Neoplasm; Soft Tissue Sarcoma
NCT02663518

Recruiting

A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors

Conditions: Hematologic Malignancies; Solid Tumor
NCT01559961

Completed

Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome

Conditions: Interstitial Cystitis